The who, what, and how of cabazitaxel treatment in metastatic castration-resistant prostate cancer

Tian Zhang; Andrew J. Armstrong

doi:10.1200/JCO.2017.74.7931

The who, what, and how of cabazitaxel treatment in metastatic castration-resistant prostate cancer

Tian Zhang, Andrew J. Armstrong

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	3175-3177
Number of pages	3
Journal	Journal of Clinical Oncology
Volume	35
Issue number	28
DOIs	https://doi.org/10.1200/JCO.2017.74.7931
State	Published - Oct 1 2017
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2017.74.7931

Cite this

@article{e7ee65ee68224d0eaca04bc38c001fd3,

title = "The who, what, and how of cabazitaxel treatment in metastatic castration-resistant prostate cancer",

author = "Tian Zhang and Armstrong, {Andrew J.}",

year = "2017",

month = oct,

day = "1",

doi = "10.1200/JCO.2017.74.7931",

language = "English (US)",

volume = "35",

pages = "3175--3177",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "28",

}

TY - JOUR

T1 - The who, what, and how of cabazitaxel treatment in metastatic castration-resistant prostate cancer

AU - Zhang, Tian

AU - Armstrong, Andrew J.

PY - 2017/10/1

Y1 - 2017/10/1

UR - http://www.scopus.com/inward/record.url?scp=85030174386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030174386&partnerID=8YFLogxK

U2 - 10.1200/JCO.2017.74.7931

DO - 10.1200/JCO.2017.74.7931

M3 - Editorial

C2 - 28809609

AN - SCOPUS:85030174386

SN - 0732-183X

VL - 35

SP - 3175

EP - 3177

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 28

ER -

The who, what, and how of cabazitaxel treatment in metastatic castration-resistant prostate cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this